![Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial - ScienceDirect Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177917303190-fx1.jpg)
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial - ScienceDirect
![Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure | Revista Portuguesa de Cardiologia (English edition) Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure | Revista Portuguesa de Cardiologia (English edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2174204917302374:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w94UphxYc+GPca8Z7OggvdfJQF4SIqTc4zp8SrbcUWBiKS3MUmaOyBgX/+OSVD6Xz3Nj1ubW2HHoj/JiiYNLEZNQC7U+wxSA2Sj2e5vRO9Soc162pv2ggKRG2q+y+PD+I5gY3DHzrRjjpQFnWkxDe16kdQvyISDSYP2exabAov5PYIFWJH56B6wfskrlh7X+0pwMs9h/IyuYXcOxnPLewshkiSyZkDPUd9XVbJjGG3JtJ1CEQTlL+BBmZzwRiVIFBo7enByMFuAoqc1k+zdoyxFk=)
Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure | Revista Portuguesa de Cardiologia (English edition)
![Figure 2 from Treatment with LCZ 696 is likely to change first-line treatment of heart failure LCZ 696 – a promising new compound in heart failure treatment | Semantic Scholar Figure 2 from Treatment with LCZ 696 is likely to change first-line treatment of heart failure LCZ 696 – a promising new compound in heart failure treatment | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6a73374092efee56be05d8b715e7adf236a5e9e2/2-Figure2-1.png)
Figure 2 from Treatment with LCZ 696 is likely to change first-line treatment of heart failure LCZ 696 – a promising new compound in heart failure treatment | Semantic Scholar
![Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure - ScienceDirect Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177914003382-gr1.jpg)
Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure - ScienceDirect
![Schematic representation to show the mode of action of an ARNI. NPs are... | Download Scientific Diagram Schematic representation to show the mode of action of an ARNI. NPs are... | Download Scientific Diagram](https://www.researchgate.net/profile/Massimo-Volpe/publication/264982341/figure/fig1/AS:268886713040901@1441118996300/Schematic-representation-to-show-the-mode-of-action-of-an-ARNI-NPs-are-degraded-to.png)
Schematic representation to show the mode of action of an ARNI. NPs are... | Download Scientific Diagram
![Figure 1 from Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. | Semantic Scholar Figure 1 from Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5012fcae2b54bdaed394fd90093b9ff610b859d3/2-Figure1-1.png)
Figure 1 from Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials. | Semantic Scholar
![Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V. - ppt video online download Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V. - ppt video online download](https://slideplayer.com/slide/4583435/15/images/2/Angiotensin+Receptor+Neprilysin+Inhibition+%28ARNI%29%3A+LCZ696.jpg)
Update on PARADIGM-HF Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial John J.V. - ppt video online download
![Mechanisms of action of the new drug LCZ696 that inhibits neprilysin... | Download Scientific Diagram Mechanisms of action of the new drug LCZ696 that inhibits neprilysin... | Download Scientific Diagram](https://www.researchgate.net/profile/Antonio-Jorge-3/publication/263015436/figure/fig5/AS:203114012516391@1425437562563/Mechanisms-of-action-of-the-new-drug-LCZ696-that-inhibits-neprilysin-and-blocks-the.png)
Mechanisms of action of the new drug LCZ696 that inhibits neprilysin... | Download Scientific Diagram
![Sacubitril/Valsartan in Management of Heart Failure: A Review of Safety, Efficacy and Cost-Effectiveness | Middle East Medical Portal Sacubitril/Valsartan in Management of Heart Failure: A Review of Safety, Efficacy and Cost-Effectiveness | Middle East Medical Portal](http://www.middleeastmedicalportal.com/wp-content/uploads/2020/07/figure-2-3-675x387.jpg)
Sacubitril/Valsartan in Management of Heart Failure: A Review of Safety, Efficacy and Cost-Effectiveness | Middle East Medical Portal
![Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Future Cardiology Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca-2020-0002/asset/images/medium/figure1.gif)
Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction | Future Cardiology
![Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure - ScienceDirect Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S174067731300020X-gr1.jpg)
Angiotensin receptor-neprilysin inhibition with LCZ696: a novel approach for the treatment of heart failure - ScienceDirect
![Angiotensin receptor neprilysin inhibitor LCZ696: pharmacology, pharmacokinetics and clinical development | Future Cardiology Angiotensin receptor neprilysin inhibitor LCZ696: pharmacology, pharmacokinetics and clinical development | Future Cardiology](https://www.futuremedicine.com/cms/10.2217/fca-2016-0057/asset/images/medium/figure2.gif)